Furthermore, the ADORA3 antagonism has the potential to block renal fibrosis in diabetic rats, since the distribution of the pro-fibrotic marker α-SMA was markedly decreased at the renal level, mainly at the tubulointertitium (Figure 6A,B). This evidence concerns the gene ACTA1 and renal fibrosis.